Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricARGXargenx SEBIIBBiogenMRNAModerna
Snapshot
Price$925.34$216.12$79.76
Market cap$55.53B$31.91B$31.65B
Valuation
P/E26x23.2x—
Forward P/E18.6x25.3x—
Growth
Revenue growth80.6%1.2%-30.0%
EPS growth111.4%-8.1%—
Profitability
Net margin48.2%13.8%-143.6%
ROE22.9%7.5%-36.7%
Balance sheet & cash
Debt / equity0.01x0.34x0.07x
Free cash flow yield—6.8%-13.6%
Dividend yield———
Verdict
Investment ratingStrong· 88Neutral· 49Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearARGXtoday $925BIIBtoday $216MRNAtoday $80
2027$1,467.27 – $2,151.99+133% CAGR$165.33 – $242.49+12% CAGR$61.02 – $89.49+12% CAGR
2028$3,102.09 – $4,549.74+122% CAGR$168.64 – $247.34+7% CAGR$62.24 – $91.28+7% CAGR
2029$6,558.44 – $9,619.05+118% CAGR$172.01 – $252.28+5% CAGR$63.48 – $93.11+5% CAGR
2030$13,865.86 – $20,336.60+117% CAGR$175.45 – $257.33+4% CAGR$64.75 – $94.97+4% CAGR
2031$29,315.21 – $42,995.63+115% CAGR$178.96 – $262.48+4% CAGR$66.05 – $96.87+4% CAGR
5-yr CAGR99.6% – 115.5%-3.7% – 4.0%-3.7% – 4.0%